Hematologic Malignancies in Children with Down Syndrome: Transient Myeloproliferative Disease and Acute Megakaryoblastic Leukemia
PDF
Cite
Share
Request
Case Report
P: 46-48
March 2015

Hematologic Malignancies in Children with Down Syndrome: Transient Myeloproliferative Disease and Acute Megakaryoblastic Leukemia

J Pediatr Res 2015;2(1):46-48
1. Ege Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İzmir, Türkiye
2. Ege Üniversitesi Fen Bilimleri Enstitüsü, Bioteknoloji Anabilim Dalı, İzmir, Türkiye. Islamic Azad Üniversitesi, Genç Araştırıcılar ve Seçkinler Kulübü Kuzey Tahran Bölümü, Tahran, İran
No information available.
No information available
Received Date: 08.05.2014
Accepted Date: 11.12.2014
PDF
Cite
Share
Request

ABSTRACT

Down Syndrome (DS) is an important genetic disease resulting from partial or total trisomy of chromosome 21 and characterized by dysmorphic facial features, intellectual disabilities and multiple congenital anomalies. Children with DS are at increased risk of developing leukemia. Specifically, 3-10% of newborns with DS are diagnosed with transient myeloproliferative disease, and children with DS are 500 times more likely to develop acute megakaryoblastic leukemia (AMKL), and 20 times more likely to develop acute lymphoblastic leukemia (ALL) than children without DS. In this study, we report two children with DS presented with transient myeloproliferative disease.

Keywords:
Down syndrome, myeloproliferative disease, acute megakaryoblastic leukemia, acute lymphoblastic leukemia